stars 1 stars 2 stars 3

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking the MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.

MARS Bioimaging Ltd Questions

The MARS Bioimaging Ltd annual revenue was $5 million in 2026.

Robert Senzig is the Vice President Clinical Engineering of MARS Bioimaging Ltd.

10 people are employed at MARS Bioimaging Ltd.

MARS Bioimaging Ltd is based in Christchurch, Canterbury.

The NAICS codes for MARS Bioimaging Ltd are [33, 334].

The SIC codes for MARS Bioimaging Ltd are [38, 384].

Top MARS Bioimaging Ltd Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users